WO2008082596A2 - Low calorie sweetener compositions - Google Patents
Low calorie sweetener compositions Download PDFInfo
- Publication number
- WO2008082596A2 WO2008082596A2 PCT/US2007/026396 US2007026396W WO2008082596A2 WO 2008082596 A2 WO2008082596 A2 WO 2008082596A2 US 2007026396 W US2007026396 W US 2007026396W WO 2008082596 A2 WO2008082596 A2 WO 2008082596A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- sweetener
- sweetener composition
- composition
- maltitol
- present
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 108
- 235000013615 non-nutritive sweetener Nutrition 0.000 title claims abstract description 34
- 239000003765 sweetening agent Substances 0.000 claims abstract description 93
- 235000003599 food sweetener Nutrition 0.000 claims abstract description 92
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 claims abstract description 40
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 claims abstract description 39
- 235000010449 maltitol Nutrition 0.000 claims abstract description 38
- 239000000845 maltitol Substances 0.000 claims abstract description 38
- 229940035436 maltitol Drugs 0.000 claims abstract description 38
- 230000002496 gastric effect Effects 0.000 claims abstract description 37
- 229920000294 Resistant starch Polymers 0.000 claims abstract description 29
- 235000021254 resistant starch Nutrition 0.000 claims abstract description 29
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims abstract description 26
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims abstract description 26
- 239000004386 Erythritol Substances 0.000 claims abstract description 25
- 235000019414 erythritol Nutrition 0.000 claims abstract description 25
- 229940009714 erythritol Drugs 0.000 claims abstract description 25
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 claims abstract description 20
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims abstract description 20
- 229920001100 Polydextrose Polymers 0.000 claims abstract description 20
- 239000001259 polydextrose Substances 0.000 claims abstract description 20
- 235000013856 polydextrose Nutrition 0.000 claims abstract description 20
- 229940035035 polydextrose Drugs 0.000 claims abstract description 20
- 239000000600 sorbitol Substances 0.000 claims abstract description 20
- 235000010356 sorbitol Nutrition 0.000 claims abstract description 20
- 239000000905 isomalt Substances 0.000 claims abstract description 19
- 235000010439 isomalt Nutrition 0.000 claims abstract description 19
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 claims abstract description 19
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims abstract description 16
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 12
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 12
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 12
- 239000004615 ingredient Substances 0.000 claims abstract description 11
- 235000013305 food Nutrition 0.000 claims description 21
- 239000008123 high-intensity sweetener Substances 0.000 claims description 14
- 238000012360 testing method Methods 0.000 claims description 12
- 235000010358 acesulfame potassium Nutrition 0.000 claims description 11
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 claims description 10
- 239000004384 Neotame Substances 0.000 claims description 10
- 229960004998 acesulfame potassium Drugs 0.000 claims description 10
- 239000000619 acesulfame-K Substances 0.000 claims description 10
- 235000019412 neotame Nutrition 0.000 claims description 10
- HLIAVLHNDJUHFG-HOTGVXAUSA-N neotame Chemical compound CC(C)(C)CCN[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 HLIAVLHNDJUHFG-HOTGVXAUSA-N 0.000 claims description 10
- 108010070257 neotame Proteins 0.000 claims description 10
- 235000013361 beverage Nutrition 0.000 claims description 8
- 150000003839 salts Chemical class 0.000 claims description 6
- 235000015173 baked goods and baking mixes Nutrition 0.000 claims description 5
- 235000010357 aspartame Nutrition 0.000 claims description 4
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 claims description 4
- 108010011485 Aspartame Proteins 0.000 claims description 3
- 229920002245 Dextrose equivalent Polymers 0.000 claims description 3
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 3
- 230000036541 health Effects 0.000 claims description 3
- 102000004169 proteins and genes Human genes 0.000 claims description 3
- 108090000623 proteins and genes Proteins 0.000 claims description 3
- 235000019408 sucralose Nutrition 0.000 claims description 3
- RMLYXMMBIZLGAQ-UHFFFAOYSA-N (-)-monatin Natural products C1=CC=C2C(CC(O)(CC(N)C(O)=O)C(O)=O)=CNC2=C1 RMLYXMMBIZLGAQ-UHFFFAOYSA-N 0.000 claims description 2
- RMLYXMMBIZLGAQ-HZMBPMFUSA-N (2s,4s)-4-amino-2-hydroxy-2-(1h-indol-3-ylmethyl)pentanedioic acid Chemical compound C1=CC=C2C(C[C@](O)(C[C@H](N)C(O)=O)C(O)=O)=CNC2=C1 RMLYXMMBIZLGAQ-HZMBPMFUSA-N 0.000 claims description 2
- NUFKRGBSZPCGQB-FLBSXDLDSA-N (3s)-3-amino-4-oxo-4-[[(2r)-1-oxo-1-[(2,2,4,4-tetramethylthietan-3-yl)amino]propan-2-yl]amino]butanoic acid;pentahydrate Chemical compound O.O.O.O.O.OC(=O)C[C@H](N)C(=O)N[C@H](C)C(=O)NC1C(C)(C)SC1(C)C.OC(=O)C[C@H](N)C(=O)N[C@H](C)C(=O)NC1C(C)(C)SC1(C)C NUFKRGBSZPCGQB-FLBSXDLDSA-N 0.000 claims description 2
- YFMPSMITLLBENU-UHFFFAOYSA-N 3,4-dihydroxybenzylamine Chemical compound NCC1=CC=C(O)C(O)=C1 YFMPSMITLLBENU-UHFFFAOYSA-N 0.000 claims description 2
- 239000004377 Alitame Substances 0.000 claims description 2
- 239000004378 Glycyrrhizin Substances 0.000 claims description 2
- 108050004114 Monellin Proteins 0.000 claims description 2
- 101000865553 Pentadiplandra brazzeana Defensin-like protein Proteins 0.000 claims description 2
- 239000004376 Sucralose Substances 0.000 claims description 2
- 235000019409 alitame Nutrition 0.000 claims description 2
- 108010009985 alitame Proteins 0.000 claims description 2
- 239000000605 aspartame Substances 0.000 claims description 2
- 229960003438 aspartame Drugs 0.000 claims description 2
- 235000013339 cereals Nutrition 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 claims description 2
- 229940109275 cyclamate Drugs 0.000 claims description 2
- HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical compound OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 claims description 2
- 235000013365 dairy product Nutrition 0.000 claims description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 claims description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 claims description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 claims description 2
- 235000019410 glycyrrhizin Nutrition 0.000 claims description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 2
- ITVGXXMINPYUHD-CUVHLRMHSA-N neohesperidin dihydrochalcone Chemical compound C1=C(O)C(OC)=CC=C1CCC(=O)C(C(=C1)O)=C(O)C=C1O[C@H]1[C@H](O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 ITVGXXMINPYUHD-CUVHLRMHSA-N 0.000 claims description 2
- 235000019204 saccharin Nutrition 0.000 claims description 2
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 claims description 2
- 229940081974 saccharin Drugs 0.000 claims description 2
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 claims description 2
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical group O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims description 2
- 235000010436 thaumatin Nutrition 0.000 claims description 2
- 239000000892 thaumatin Substances 0.000 claims description 2
- 241000544066 Stevia Species 0.000 claims 2
- 239000001329 FEMA 3811 Substances 0.000 claims 1
- 229940089953 neohesperidin dihydrochalcone Drugs 0.000 claims 1
- 235000010434 neohesperidine DC Nutrition 0.000 claims 1
- 229920002472 Starch Polymers 0.000 description 20
- 235000019698 starch Nutrition 0.000 description 20
- 239000008107 starch Substances 0.000 description 18
- 208000024891 symptom Diseases 0.000 description 16
- 229960002920 sorbitol Drugs 0.000 description 15
- 206010012735 Diarrhoea Diseases 0.000 description 12
- 235000012970 cakes Nutrition 0.000 description 11
- 230000003187 abdominal effect Effects 0.000 description 9
- 150000005846 sugar alcohols Chemical class 0.000 description 9
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 8
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 8
- UGTZMIPZNRIWHX-UHFFFAOYSA-K sodium trimetaphosphate Chemical compound [Na+].[Na+].[Na+].[O-]P1(=O)OP([O-])(=O)OP([O-])(=O)O1 UGTZMIPZNRIWHX-UHFFFAOYSA-K 0.000 description 8
- 230000029087 digestion Effects 0.000 description 7
- 239000008103 glucose Substances 0.000 description 7
- 229920000728 polyester Polymers 0.000 description 7
- 238000009472 formulation Methods 0.000 description 6
- 235000019832 sodium triphosphate Nutrition 0.000 description 6
- 206010000060 Abdominal distension Diseases 0.000 description 5
- 102000004139 alpha-Amylases Human genes 0.000 description 5
- 108090000637 alpha-Amylases Proteins 0.000 description 5
- 208000024330 bloating Diseases 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 206010016766 flatulence Diseases 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 229920005862 polyol Polymers 0.000 description 5
- 150000003077 polyols Chemical class 0.000 description 5
- 210000000813 small intestine Anatomy 0.000 description 5
- 241000282412 Homo Species 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 229940024171 alpha-amylase Drugs 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 230000000865 phosphorylative effect Effects 0.000 description 4
- 239000002002 slurry Substances 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000003431 cross linking reagent Substances 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 230000001079 digestive effect Effects 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- FGOJCPKOOGIRPA-UHFFFAOYSA-N 1-o-tert-butyl 4-o-ethyl 5-oxoazepane-1,4-dicarboxylate Chemical compound CCOC(=O)C1CCN(C(=O)OC(C)(C)C)CCC1=O FGOJCPKOOGIRPA-UHFFFAOYSA-N 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 229920001685 Amylomaize Polymers 0.000 description 2
- 244000024675 Eruca sativa Species 0.000 description 2
- 235000014755 Eruca sativa Nutrition 0.000 description 2
- 206010017943 Gastrointestinal conditions Diseases 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- 240000003183 Manihot esculenta Species 0.000 description 2
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 2
- 244000061456 Solanum tuberosum Species 0.000 description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 description 2
- 244000228451 Stevia rebaudiana Species 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 235000008429 bread Nutrition 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- ZAASRHQPRFFWCS-UHFFFAOYSA-P diazanium;oxygen(2-);uranium Chemical compound [NH4+].[NH4+].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[U].[U] ZAASRHQPRFFWCS-UHFFFAOYSA-P 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical group ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229920001592 potato starch Polymers 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- GLDQAMYCGOIJDV-UHFFFAOYSA-N 2,3-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC=CC(O)=C1O GLDQAMYCGOIJDV-UHFFFAOYSA-N 0.000 description 1
- WRFYIYOXJWKONR-UHFFFAOYSA-N 4-bromo-2-methoxyaniline Chemical compound COC1=CC(Br)=CC=C1N WRFYIYOXJWKONR-UHFFFAOYSA-N 0.000 description 1
- PVXPPJIGRGXGCY-TZLCEDOOSA-N 6-O-alpha-D-glucopyranosyl-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)C(O)(CO)O1 PVXPPJIGRGXGCY-TZLCEDOOSA-N 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 229920000945 Amylopectin Polymers 0.000 description 1
- 229920000856 Amylose Polymers 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 241000209763 Avena sativa Species 0.000 description 1
- 235000007558 Avena sp Nutrition 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 239000004971 Cross linker Substances 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 1
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 239000004368 Modified starch Substances 0.000 description 1
- 240000008790 Musa x paradisiaca Species 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 102000001746 Pancreatic alpha-Amylases Human genes 0.000 description 1
- 108010029785 Pancreatic alpha-Amylases Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000245026 Scoliopus bigelovii Species 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 240000004922 Vigna radiata Species 0.000 description 1
- 235000010721 Vigna radiata var radiata Nutrition 0.000 description 1
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 description 1
- 238000001793 Wilcoxon signed-rank test Methods 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- YGCFIWIQZPHFLU-UHFFFAOYSA-N acesulfame Chemical compound CC1=CC(=O)NS(=O)(=O)O1 YGCFIWIQZPHFLU-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 235000015496 breakfast cereal Nutrition 0.000 description 1
- 235000012467 brownies Nutrition 0.000 description 1
- 239000004067 bulking agent Substances 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 235000012182 cereal bars Nutrition 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- XENVCRGQTABGKY-ZHACJKMWSA-N chlorohydrin Chemical compound CC#CC#CC#CC#C\C=C\C(Cl)CO XENVCRGQTABGKY-ZHACJKMWSA-N 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 235000013353 coffee beverage Nutrition 0.000 description 1
- 230000000112 colonic effect Effects 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 239000001245 distarch phosphate Substances 0.000 description 1
- 235000013804 distarch phosphate Nutrition 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 235000021237 low-digestible carbohydrates Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 229930188195 rebaudioside Natural products 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 235000013570 smoothie Nutrition 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000021092 sugar substitutes Nutrition 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/346—Finished or semi-finished products in the form of powders, paste or liquids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/343—Products for covering, coating, finishing, decorating
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
- A23L27/33—Artificial sweetening agents containing sugars or derivatives
- A23L27/34—Sugar alcohols
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/212—Starch; Modified starch; Starch derivatives, e.g. esters or ethers
- A23L29/219—Chemically modified starch; Reaction or complexation products of starch with other chemicals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Definitions
- Low calorie sweeteners have gained widespread use because of the demand for low calorie foods and beverages that mimic the taste of higher calorie food and beverages that are prepared with sugar.
- many low calorie sweetener compositions cause gastrointestinal intolerance when consumed in typical amounts. Examples include sugar alcohols such as erythritol, maltitol, isomalt, sorbitol, mannitol, and xylitol; and low digestibility oligosaccharides.
- Gastrointestinal intolerance typically includes undesirable symptoms such as gastrointestinal rumbling, abdominal cramping, gas, bloating, excessive flatulence, loose stools, and diarrhea.
- a low calorie sweetener composition that is suitable for use in foods (e.g., baked goods) and beverages that has improved gastrointestinal tolerance when consumed by humans.
- the invention is directed to low calorie sweetener compositions.
- Embodiments of the low calorie sweetener compositions of the invention have improved gastrointestinal tolerance in humans.
- embodiments of the low calorie sweetener of the invention have improved gastrointestinal tolerance when compared to maltitol.
- Gastrointestinal tolerance can be measured, for example, using human studies where test foods comprising the sweetener to be tested and a comparative sweetener are consumed by human subjects in controlled fashion, and the human subjects rate the foods for gastrointestinal effects including, for example, gastrointestinal rumbling, abdominal cramping, gas, bloating, excessive flatulence, loose stools, and diarrhea.
- the invention is directed to low calorie sweetener compositions comprising: (a) about 5 wt.% to about 40 wt.% erythritol; (b) about 0 wt.% to about 30 wt.% sorbitol; (c) about 0 wt.% to about 50 wt.% of an ingredient selected from the group consisting of isomalt, maltitol, or a mixture thereof; (d) about 5 wt.% to about 40 wt.% polydextrose; and (e) about 5 wt.% to about 40 wt.% resistant starch.
- the low calorie sweetener compositions of the first aspect comprise: (a) about 25 wt.% to about 35 wt.% erythritol; (b) about 10 wt.% to about 20 wt.% sorbitol; (c) about 25 wt.% to about 30 wt.% isomalt, maltitol, or a mixture thereof; (d) about 5 wt.% to about 20 wt.% resistant starch; and (e) about 10 wt.% to about 20 wt.% polydextrose.
- the invention is directed to low calorie sweetener compositions comprising: (a) about 5 wt.% to about 40 wt.% erythritol; (b) up to about 68 wt.% of an ingredient selected from isomalt, maltitol, sorbitol, or a mixture thereof; (c) about 5 wt.% to about 40 wt.% of an ingredient selected from polydextrose, resistant maltodextrin, or a mixture thereof.
- the low calorie sweetener comprises about 29 wt.% polydextrose, about 57% maltitol, and 14% erythritol.
- Low calorie sweetener compositions of the invention may further comprise one or more high intensity sweeteners, such as acesulfame potassium and neotame.
- the invention is directed to foods, such as baked goods and beverages that comprise the low calorie sweetener compositions of the invention.
- the invention is directed to low calorie sweetener compositions.
- Embodiments of the low calorie sweetener compositions of the invention have improved gastrointestinal tolerance in humans.
- the ingredients making up the sweetener compositions of the invention are described in more detail below.
- Ervthritol Sweetener compositions of the invention comprise erythritol.
- Erythritol or tetrahydroxybutane is a tetrahydric polyol or sugar alcohol that has the empirical formula C 4 H 10 O 4 and the structural formula CH 2 OH-CHOH-CHOH-CH 2 OH.
- Erythritol has a low caloric content of about 0.2 calories/gram.
- Erythritol has a sweetness level that is about 75% that of sucrose. Due to its small molecular size, erythritol behaves differently than other polyols that are used as sugar substitutes. Erythritol is absorbed very quickly in the small intestine and is not subject to metabolic conversion in the body. Because of this, erythritol has a higher digestive tolerance than other sugar alcohols. Erythritol is typically manufactured synthetically by fermenting glucose with special yeast strains in appropriate aqueous nutrient media, or by treating an aqueous alkali carbonate solution of 2-buten-l,4-diol with chlorine, and saponifying the resulting chlorohydrin.
- Erythritol is typically provided as a white crystalline powder that has a melting point of about 120°C. Erythritol is present in the sweetener compositions of the invention in an amount ranging from about 5 wt.% to about 40 wt.%. In more preferred embodiments, erythritol is present in an amount ranging from about 25 wt.% to about 35 wt.%. Erythritol may be obtained commercially under the trade designation "ERIDEX" (from Cargill Specialty Sweeteners division of Cargill, Incorporated). Sorbitol: .
- the sweetener compositions of the invention comprise sorbitol.
- Sorbitol is a sugar alcohol that has the formula C 6 Hg(OH) 6 . Sorbitol is obtained by reducing the aldehyde group in glucose to form an alcohol group. Sorbitol is a nutrituve sweetener providing about 2.6 calories/gram. Sorbitol has a sweetness level that is about 60% that of sucrose. Because it metabolizes slowly, ingestion of large amounts of sorbitol may in some instances lead to gastrointestinal intolerance such as abdominal pain, gas, and diarrhea.
- Sorbitol may be obtained commercially under the trade designation "SORBIDEX” (from Cerestar division of Cargill, Incorporated). Isomalt:
- the sweetener compositions of the invention comprise isomalt.
- Isomalt is a sugar alcohol that comprises two components: 1,6- glucopyranosyl-D-sorbitol (GPS) and 1,1-glucopyranosyl-D-mannitol (GPM), in a 1 : 1 ratio.
- Isomalt is an odorless, white, crystalline substance which typically contains about 5% water. Isomalt has about 2 calories/gram. Like most sugar alcohols, ingestion of large amounts of isomalt may in some instances lead to gastrointestinal intolerance such as abdominal pain, gas, and diarrhea. Isomalt is typically derived from sucrose by enzymatic conversion into isomaltulose, which is then hydrogenated to obtain the two component mixture of GPS and GPM.
- the sweetener compositions of the invention comprise maltitol.
- Maltitol is a polyol or sugar alcohol type sweetener.
- Maltitol is disaccharide consisting of glucose and sorbitol.
- As a sweetener maltitol has about 90% of the sweetness of sugar and has nearly identical properties, except for browning.
- Maltitol may be manufactured by the catalytic hydrogenation of high maltose corn syrup, which transforms the maltose to the sugar alcohol maltitol. It is often provided in as a syrup, or in solid form as a white crystalline powder.
- Maltitol powders and syrups typically comprise about 50 wt.% to 90 wt.% maltitol.
- Maltitol provides about 2.1 calories/gram, approximately 75% that of sugar. Being a sugar alcohol, maltitol is known to cause gastric distress, particularly if consumed in large quantities.
- maltitol When present, maltitol is typically present in the sweetener compositions of the invention in an amount up to about 50 wt.%. In preferred embodiments, maltitol is present in an amount ranging from about 15 wt.% to about 45 wt.%. Maltitol may be obtained commercially under the trade designation "MALTISORB" (from
- the sweetener compositions of the invention comprise polydextrose.
- Polydextrose is a non-sweet, water-soluble, low-calorie, bulking agent that can provide both bulk and texture properties that are similar to sugar when used in sweetener compositions.
- polydextrose is a randomly bonded highly branched glucose polymer.
- Polydextrose can be synthesized by the acid catalyzed condensation of glucose.
- polydextrose is made from glucose, sorbitol, and citric acid. Synthesis of polydextrose is described, for example, in U.S. Pat. Nos. 3,766,165 and 3,876,794. Polydextrose provides about 1 calorie/gram.
- Polydextrose can be obtained commercially under the trade designation "LITESSE” (from Danisco, Company) and StaLite III (from Tate and LyIe). Resistant Starch:
- the sweetener compositions of the invention comprise resistant starch.
- Resistant starch is a special form of starch that resists digestion in the small intestine.
- Sarch is a complex carbohydrate that is made up of two types of polysaccharide molecules: amylase and amylopectin.
- Starch is predominately digested in the small intestine because of the action of the enzyme alpha-amylase.
- conventional starch can be transformed into resistant starch, a type of starch that is resistant to enzymatic hydrolysis in the small intestine.
- Resistant starch can be classified into four general types depending on the mechanism of its digestive resistance.
- RSl is a physically inaccessible starch due to entrapment of granules within a protein matrix or within a plant cell wall. Examples include partly milled grains, seeds, and legumes.
- RS2 is a granular starch that resists digestion by pancreatic alpha-amylase. Examples include native uncooked potato starch and green banana.
- RS3 is a non-granular retrograded or crystalline starch. Examples include cooled-cooked potato, bread, and breakfast cereals.
- RS4 is chemically modified resistant starch that has some linkages other than alpha-1,4- and alpha- 1 ,6-D-glucosidic bonds.
- U.S. Pat. No. 5,593,503 describes a method of making a granular resistant starch.
- U.S. Pat. Nos. 5,281,276 and 5,409,542 describe methods of making resistant starches of the RS3 type from high amylose starches.
- U.S. Pat. No. 6,043,229 discloses a partially degraded and retrograded resistant starch.
- the sweetener compositions of the invention comprise a RS3 type resistant starch.
- Type RS3 resistant starch may be prepared by enzymatic de-branching of a tapioca maltodextrin and subsequent retrogradation. During retrogradation, slightly hydrolysed amylose (i.e., the linear carbohydrate chain in starch) forms double-helical crystalline structures called crystallites.
- AOAC American Association of Analytical Chemists
- the resistant starches have 35% or greater resistance, and most preferably 50% or greater resistance to alpha-amylase digestion.
- the reported starches can be prepared from any type of starting starch (e.g., wheat, corn, oat, rice, tapioca, mung bean, potato or high amylose starches).
- the cross-linked starches are most preferably phosphorylated to form distarch phosphate diesters and typically contain at least 0.1 wt.% residual phosphorous, and more preferably at least about 0.2 wt.% residual phosphorous.
- the preferred phosphorylating agent is a mixture of sodium trimetaphosphate (STMP) and sodium tripolyphosphate (STPP) in the presence of sodium chloride or sulfate.
- the mixture comprises from about 1-20 wt.% STMP (most preferably from about 5-12 wt.% STMP) and from about 0.01-0.2 wt.% STPP (most preferably from about 0.05-0.12 wt.% STPP).
- Another useful phosphorylating agent is phosphoryl chloride.
- other cross-linking agents such as adipic acid or epichlorohydrin may also be used.
- the RS4 starch of U.S. Patent No. 5,855,946 may be prepared by reacting a starting (usually native and unmodified) starch in the presence of water and a cross- linking agent under conditions of pH and temperature to yield a modified starch having the desired alpha-amylase digestion properties.
- the preferred preparation method involves initially forming a slurry of the starting starch in water and adding the cross-linking agent to the slurry.
- the slurry typically has about 15-60 wt.% starch, and more preferably from about 30-50 wt.% starch.
- the preferred phosphorylating cross-linker would be STMP alone or a mixture of STMP and STPP.
- the reaction need be carried out only for a sufficient time to provide the requisite degree of alpha-amylase digestion resistance, for example, a period of about 10 minutes to about 24 hours, more preferably from about 1-3 hours.
- STMP or the STMP/STPP mixture is used as the phosphorylating agent, it is sometimes preferred to add an amount (from about 0.1-20% by weight, based upon the weight of the starting starch taken as 100% by weight) of sodium sulfate or sodium chloride to the slurry.
- the presence of one of these salts serves to retard gel formation during the reaction and to accelerate the reaction by increasing the base adsorbed by the starch granules.
- Useful resistant starch has a dextrose equivalent of about 100.
- Dextrose equivalent as used herein, is intended to mean the reducing power of the hydrolysate. Since each starch molecule has one reducing end, DE is inversely related to molecular weight. The DE of anhydrous D-glucose is defined as 100 and the DE of unhydrolyzed starch is almost zero.
- Maltodextrin typically has a DE of about 5 to 20. Some types of resistant maltodextrin have a DE of about 8 to 12.5.
- Useful resistant starch may be obtained commercially under the trade designation "ACTISTAR RT” (from Cargill Texturizing Solutions). Resistant Maltodextrin:
- the sweetener compositions of the invention comprise resistant maltodextrin.
- a resistant maltodextrin is defined as a short chain polymer of glucose that is resistant to digestion in the human digestive system. Suitable resistant maltodextrin is commercially available under the trade designation "FIBERSOL-2" (from Archer Daniels Midland Company, Decatur, IL) High Intensity Sweetener:
- the sweetener compositions of the invention comprise a natural or synthetic high intensity sweetener.
- useful high intensity sweeteners include sucralose (l ,6-dichloro-l,6-dideoxy- ⁇ -D-fructo-furanosyl 4- chloro ⁇ -deoxy- ⁇ -D-galactopyranoside; "SPLENDA” from Tate & LyIe), acesulfame potassium (potassium salt of 6-methyl- 1,2,3- oxathiazine-4(3H)-one 2,2- dioxide; (SUNETT” from Nutrinova)), N-[N-(3,3-dimethylbutyl)-L-aspartyl]-L- phenylaniline 1 -methyl ester ("NEOTAME” from NutraSweet), aspartame (7V-L-a- aspartyl-L-phenylalanine 1 -methyl ester ("EQUAL” from Merisant Co.)), saccharin, alitame
- a high intensity sweetener When included, a high intensity sweetener is typically incorporated in an amount up to about 0.4 wt.% of the composition, for example, about 0.1 wt.% to about 0.2 wt.%.
- a combination of two or more high intensity sweeteners is used.
- a useful combination of high intensity sweeteners is acesulfame potassium and neotame. The use of these two high intensity sweeteners has been found to provide a desirable sweetness profile. Acesulfame potassium tends to provide an initial sweet taste whereas neotame acts to maintain a sweet flavor profile over time.
- the weight ratio of acesulfame potassium to neotame in the sweetener composition ranges from about 8: 1 to about 16.7: 1 , more typically ranging from about 9: 1 to about 10: 1. Based upon the weight of the formulation, the amount of acesulfame potassium typically ranges from about 0.09 wt.% to about 0.18 wt.% and the amount of neotame typically ranges from about 0.006 wt.% to about 0.01 1 wt.%.
- the sweetener compositions of the invention may be utilized for any application where a sugar-free sweetener is desired.
- the sweetener composition may be used in a food or a beverage.
- Typical applications of the sweetener composition include baked goods such as breads, cookies, cakes, brownies, and the like; beverages such as coffee and soft drinks; confections such as chocolates, candies, the like; dairy products such as cheesecake, ice cream, smoothies, yogurt, and the like; cereal bars, health bars, protein bars and the like.
- the sweetener compositions of the invention may be manufactured in any manner. Typically, the compositions are produced by mixing or dry blending the components making up the sweetener composition. Digestive Tolerance:
- the sweetener compositions of the invention have improved gastrointestinal tolerance in humans.
- the sweetener compositions of the invention have improved gastrointestinal tolerance as compared to maltitol.
- Gastrointestinal tolerance can be measured, for example, using a randomized, double blind, crossover, repeated measure design protocol, such described in Test Protocol 1 in the Example section of the application.
- a test food comprising a sweetener to be tested is consumed by human subjects, and the subjects are required to complete a gastrointestinal survey at various intervals, prior to and after, consuming the test food.
- the human subject may complete the survey at 0 hours (i.e., just prior to consuming the test food), 2 hours, 6 hours, 12 hours, and 24 hours after consuming the test food.
- the food is then rated at the various time periods for gastrointestinal tolerance as evidenced by gastrointestinal effects such as gastrointestinal rumbling, abdominal cramping, gas/bloating, excessive flatulence, loose stools, and diarrhea.
- the reduction in one or more of these gastrointestinal effects is evidence of improved gastrointestinal tolerance for the sweetener composition as compared to the comparative sweetener (e.g., maltitol).
- improved gastrointestinal tolerance is evidenced by a reduction in more than one gastrointestinal effect for the sweetener composition as compared to the comparative sweetener composition.
- Sweetener 1 was an embodiment of the present invention.
- Comparative Sweetener A consisted of 100% maltitol.
- Comparative Sweetener B was a comparative sweetener composition comprising resistant maltodextrin.
- Cake batters were prepared having the recipe shown in TABLE 1. Each cake batter was prepared from a standard yellow cake base having the ingredients shown in TABLE 2.
- each cupcake was iced with an icing composition comprising the same sweetener that was used in the cake batter. That is, Cake Batter 1 was used with Icing Formulation 1 to provide a cupcake comprising SWEETENER 1 ; Cake Batter 2 was used with Icing Formulation 2 to provide a cupcake comprising COMP. SWEETENER A; and Cake Batter 3 was used with Icing Formulation 3 to provide a cupcake comprising COMP. SWEETENER B.
- the white icings had the recipes listed in TABLE 3.
- the gastrointestinal symptoms increased after consuming the cupcakes and peaked after 6 hours.
- the gastrointestinal symptoms generally returned to baseline after 24 hours.
- Significantly milder gastrointestinal symptoms were reported for several of the symptoms after consuming the cupcakes comprising SWEETENER 1 when compared to the cupcakes comprising COMP.
- SWEETNER A significantly milder gastrointestinal symptoms were reported for several of the symptoms after consuming the cupcakes comprising COMP.
- SWEETENER B when compared to the cupcakes comprising COMP.
- SWEETNER A More specifically, significantly milder gastrointestinal rumbling, abdominal cramping, abdominal gas/bloating and excessive flatulence symptoms were reported 6 hours after consumption for the cupcakes comprising SWEETENER 1 as compared to the cupcakes comprising COMP.
- SWEETENER A and also as compared to the cupcakes comprising COMP. SWEETENER B.
- Significantly milder abdominal cramping was reported for COMP. SWEETENER B as compared to COMP. SWEETENER A at 12 hours after consumption.
- Significantly milder abdominal cramping was reported after 24 hours for COMP. SWEETENER A as compared to SWEETENER 1.
- Shaded blocks identify comparisons having a significant P-value of P ⁇ 0.05.
- the milder symptoms experienced after ingesting foods comprising SWEETENER 1 may be attributed to the composition of the sweetener.
- Erythritol is a better tolerated low-digestible carbohydrate as compared to maltitol because about
- SWEETENER 1 was observed to be better tolerated than maltitol.
Abstract
The invention is directed to low calorie sweetener compositions. In some embodiments, the sweetener compositions comprise: (a) about 5 wt.% to about 40 wt.% erythritol; (b) about 0 wt.% to about 30 wt.% sorbitol; (c) about 0 wt.% to about 50 wt.% of an ingredient selected from the group consisting of isomalt, maltitol, or a mixture thereof; (d) about 5 wt.% to about 40 wt.% polydextrose; and (e) about 5 wt.% to about 40 wt.% resistant starch. In other embodiments, the sweetener compositions comprise: (a) about 5 wt.% to about 40 wt.% erythritol; (b) up to about 68 wt.% of an ingredient selected from isomalt, maltitol, sorbitol, or a mixture thereof; (c) about 5 wt.% to about 40 wt.% of an ingredient selected from polydextrose, resistant maltodextrin, or a mixture thereof. Embodiments of the low calorie sweetener compositions display improved gastrointestinal tolerance when consumed by humans.
Description
LOW CALORIE SWEETENER COMPOSITIONS
CROSS-REFERENCE TO RELATED APPLICATIONS This application claims priority to U.S. Provisional Application Serial
Number 60/877,525, filed December 28, 2006, the disclosure of which is incorporated herein by reference.
BACKGROUND Low calorie sweeteners have gained widespread use because of the demand for low calorie foods and beverages that mimic the taste of higher calorie food and beverages that are prepared with sugar. However, many low calorie sweetener compositions cause gastrointestinal intolerance when consumed in typical amounts. Examples include sugar alcohols such as erythritol, maltitol, isomalt, sorbitol, mannitol, and xylitol; and low digestibility oligosaccharides. Gastrointestinal intolerance typically includes undesirable symptoms such as gastrointestinal rumbling, abdominal cramping, gas, bloating, excessive flatulence, loose stools, and diarrhea.
In view of the undesirable effects resulting from certain low calorie sweeteners, what is desired is a low calorie sweetener composition that is suitable for use in foods (e.g., baked goods) and beverages that has improved gastrointestinal tolerance when consumed by humans.
SUMMARY The invention is directed to low calorie sweetener compositions.
Embodiments of the low calorie sweetener compositions of the invention have improved gastrointestinal tolerance in humans. For example, embodiments of the low calorie sweetener of the invention have improved gastrointestinal tolerance when compared to maltitol. Gastrointestinal tolerance can be measured, for example, using human studies where test foods comprising the sweetener to be tested and a comparative sweetener are consumed by human subjects in controlled fashion, and the human subjects rate the foods for gastrointestinal effects including,
for example, gastrointestinal rumbling, abdominal cramping, gas, bloating, excessive flatulence, loose stools, and diarrhea.
In one aspect, the invention is directed to low calorie sweetener compositions comprising: (a) about 5 wt.% to about 40 wt.% erythritol; (b) about 0 wt.% to about 30 wt.% sorbitol; (c) about 0 wt.% to about 50 wt.% of an ingredient selected from the group consisting of isomalt, maltitol, or a mixture thereof; (d) about 5 wt.% to about 40 wt.% polydextrose; and (e) about 5 wt.% to about 40 wt.% resistant starch.
In preferred embodiments of the invention, the low calorie sweetener compositions of the first aspect comprise: (a) about 25 wt.% to about 35 wt.% erythritol; (b) about 10 wt.% to about 20 wt.% sorbitol; (c) about 25 wt.% to about 30 wt.% isomalt, maltitol, or a mixture thereof; (d) about 5 wt.% to about 20 wt.% resistant starch; and (e) about 10 wt.% to about 20 wt.% polydextrose.
In a second aspect, the invention is directed to low calorie sweetener compositions comprising: (a) about 5 wt.% to about 40 wt.% erythritol; (b) up to about 68 wt.% of an ingredient selected from isomalt, maltitol, sorbitol, or a mixture thereof; (c) about 5 wt.% to about 40 wt.% of an ingredient selected from polydextrose, resistant maltodextrin, or a mixture thereof. In a preferred aspect, the low calorie sweetener comprises about 29 wt.% polydextrose, about 57% maltitol, and 14% erythritol. Low calorie sweetener compositions of the invention may further comprise one or more high intensity sweeteners, such as acesulfame potassium and neotame. In yet another aspect, the invention is directed to foods, such as baked goods and beverages that comprise the low calorie sweetener compositions of the invention.
DETAILED DESCRIPTION
In one aspect, the invention is directed to low calorie sweetener compositions. Embodiments of the low calorie sweetener compositions of the invention have improved gastrointestinal tolerance in humans. The ingredients making up the sweetener compositions of the invention are described in more detail below. Ervthritol:
Sweetener compositions of the invention comprise erythritol. Erythritol or tetrahydroxybutane is a tetrahydric polyol or sugar alcohol that has the empirical formula C4H10O4 and the structural formula CH2OH-CHOH-CHOH-CH2OH. Erythritol has a low caloric content of about 0.2 calories/gram. Erythritol has a sweetness level that is about 75% that of sucrose. Due to its small molecular size, erythritol behaves differently than other polyols that are used as sugar substitutes. Erythritol is absorbed very quickly in the small intestine and is not subject to metabolic conversion in the body. Because of this, erythritol has a higher digestive tolerance than other sugar alcohols. Erythritol is typically manufactured synthetically by fermenting glucose with special yeast strains in appropriate aqueous nutrient media, or by treating an aqueous alkali carbonate solution of 2-buten-l,4-diol with chlorine, and saponifying the resulting chlorohydrin. Erythritol is typically provided as a white crystalline powder that has a melting point of about 120°C. Erythritol is present in the sweetener compositions of the invention in an amount ranging from about 5 wt.% to about 40 wt.%. In more preferred embodiments, erythritol is present in an amount ranging from about 25 wt.% to about 35 wt.%. Erythritol may be obtained commercially under the trade designation "ERIDEX" (from Cargill Specialty Sweeteners division of Cargill, Incorporated). Sorbitol: .
In some embodiments, the sweetener compositions of the invention comprise sorbitol. Sorbitol is a sugar alcohol that has the formula C6Hg(OH)6. Sorbitol is obtained by reducing the aldehyde group in glucose to form an alcohol group. Sorbitol is a nutrituve sweetener providing about 2.6 calories/gram. Sorbitol has a sweetness level that is about 60% that of sucrose. Because it metabolizes slowly, ingestion of large amounts of sorbitol may in some instances lead to gastrointestinal intolerance such as abdominal pain, gas, and diarrhea.
Sorbitol may be obtained commercially under the trade designation "SORBIDEX" (from Cerestar division of Cargill, Incorporated).
Isomalt:
In some embodiments, the sweetener compositions of the invention comprise isomalt. Isomalt is a sugar alcohol that comprises two components: 1,6- glucopyranosyl-D-sorbitol (GPS) and 1,1-glucopyranosyl-D-mannitol (GPM), in a 1 : 1 ratio.
Isomalt is an odorless, white, crystalline substance which typically contains about 5% water. Isomalt has about 2 calories/gram. Like most sugar alcohols, ingestion of large amounts of isomalt may in some instances lead to gastrointestinal intolerance such as abdominal pain, gas, and diarrhea. Isomalt is typically derived from sucrose by enzymatic conversion into isomaltulose, which is then hydrogenated to obtain the two component mixture of GPS and GPM.
Isomalt may be obtained commercially under the trade designation "ISOMALTIDEX" (from Cerestar division of Cargill, Incorporated). Maltitol: In some embodiments, the sweetener compositions of the invention comprise maltitol. Maltitol is a polyol or sugar alcohol type sweetener. Maltitol is disaccharide consisting of glucose and sorbitol. As a sweetener, maltitol has about 90% of the sweetness of sugar and has nearly identical properties, except for browning. Maltitol may be manufactured by the catalytic hydrogenation of high maltose corn syrup, which transforms the maltose to the sugar alcohol maltitol. It is often provided in as a syrup, or in solid form as a white crystalline powder. Maltitol powders and syrups typically comprise about 50 wt.% to 90 wt.% maltitol.
Maltitol provides about 2.1 calories/gram, approximately 75% that of sugar. Being a sugar alcohol, maltitol is known to cause gastric distress, particularly if consumed in large quantities.
When present, maltitol is typically present in the sweetener compositions of the invention in an amount up to about 50 wt.%. In preferred embodiments, maltitol is present in an amount ranging from about 15 wt.% to about 45 wt.%. Maltitol may be obtained commercially under the trade designation "MALTISORB" (from
Roquette); "MALTISWEET" (from SPI Polyols); and "MALTIDEX" (from Cargill Sweetness Solutions division of Cargill, Incorporated).
Polydextrose:
In some embodiments, the sweetener compositions of the invention comprise polydextrose. Polydextrose is a non-sweet, water-soluble, low-calorie, bulking agent that can provide both bulk and texture properties that are similar to sugar when used in sweetener compositions.
Chemically, polydextrose is a randomly bonded highly branched glucose polymer. Polydextrose can be synthesized by the acid catalyzed condensation of glucose. In many embodiments, polydextrose is made from glucose, sorbitol, and citric acid. Synthesis of polydextrose is described, for example, in U.S. Pat. Nos. 3,766,165 and 3,876,794. Polydextrose provides about 1 calorie/gram.
Polydextrose can be obtained commercially under the trade designation "LITESSE" (from Danisco, Company) and StaLite III (from Tate and LyIe). Resistant Starch:
In some embodiments, the sweetener compositions of the invention comprise resistant starch. Resistant starch is a special form of starch that resists digestion in the small intestine. Sarch is a complex carbohydrate that is made up of two types of polysaccharide molecules: amylase and amylopectin. Starch is predominately digested in the small intestine because of the action of the enzyme alpha-amylase. Through certain processing techniques, conventional starch can be transformed into resistant starch, a type of starch that is resistant to enzymatic hydrolysis in the small intestine.
Resistant starch can be classified into four general types depending on the mechanism of its digestive resistance. RSl is a physically inaccessible starch due to entrapment of granules within a protein matrix or within a plant cell wall. Examples include partly milled grains, seeds, and legumes. RS2 is a granular starch that resists digestion by pancreatic alpha-amylase. Examples include native uncooked potato starch and green banana. RS3 is a non-granular retrograded or crystalline starch. Examples include cooled-cooked potato, bread, and breakfast cereals. RS4 is chemically modified resistant starch that has some linkages other than alpha-1,4- and alpha- 1 ,6-D-glucosidic bonds.
Various methods have been reported for producing resistant starch. For example, U.S. Pat. No. 5,593,503 describes a method of making a granular resistant
starch. U.S. Pat. Nos. 5,281,276 and 5,409,542 describe methods of making resistant starches of the RS3 type from high amylose starches. U.S. Pat. No. 6,043,229 discloses a partially degraded and retrograded resistant starch.
In some embodiments, the sweetener compositions of the invention comprise a RS3 type resistant starch. Type RS3 resistant starch may be prepared by enzymatic de-branching of a tapioca maltodextrin and subsequent retrogradation. During retrogradation, slightly hydrolysed amylose (i.e., the linear carbohydrate chain in starch) forms double-helical crystalline structures called crystallites. A particularly useful RS4 resistant starch is reported in U.S. Patent No. 5,855,946. These resistant starches are reported to exhibit at least about a 20% resistance to alpha-amylase digestion, as measured using American Association of Analytical Chemists (AOAC) Method 992.16 (1995). In some embodiments, the resistant starches have 35% or greater resistance, and most preferably 50% or greater resistance to alpha-amylase digestion. The reported starches can be prepared from any type of starting starch (e.g., wheat, corn, oat, rice, tapioca, mung bean, potato or high amylose starches). The cross-linked starches are most preferably phosphorylated to form distarch phosphate diesters and typically contain at least 0.1 wt.% residual phosphorous, and more preferably at least about 0.2 wt.% residual phosphorous. The preferred phosphorylating agent is a mixture of sodium trimetaphosphate (STMP) and sodium tripolyphosphate (STPP) in the presence of sodium chloride or sulfate. Generally, where the mixture is used, it comprises from about 1-20 wt.% STMP (most preferably from about 5-12 wt.% STMP) and from about 0.01-0.2 wt.% STPP (most preferably from about 0.05-0.12 wt.% STPP). Another useful phosphorylating agent is phosphoryl chloride. In addition, other cross-linking agents such adipic acid or epichlorohydrin may also be used.
The RS4 starch of U.S. Patent No. 5,855,946 may be prepared by reacting a starting (usually native and unmodified) starch in the presence of water and a cross- linking agent under conditions of pH and temperature to yield a modified starch having the desired alpha-amylase digestion properties. The preferred preparation method involves initially forming a slurry of the starting starch in water and adding the cross-linking agent to the slurry. The slurry typically has about 15-60 wt.%
starch, and more preferably from about 30-50 wt.% starch. The preferred phosphorylating cross-linker would be STMP alone or a mixture of STMP and STPP. The reaction need be carried out only for a sufficient time to provide the requisite degree of alpha-amylase digestion resistance, for example, a period of about 10 minutes to about 24 hours, more preferably from about 1-3 hours. Where STMP or the STMP/STPP mixture is used as the phosphorylating agent, it is sometimes preferred to add an amount (from about 0.1-20% by weight, based upon the weight of the starting starch taken as 100% by weight) of sodium sulfate or sodium chloride to the slurry. The presence of one of these salts serves to retard gel formation during the reaction and to accelerate the reaction by increasing the base adsorbed by the starch granules.
Useful resistant starch has a dextrose equivalent of about 100. Dextrose equivalent, as used herein, is intended to mean the reducing power of the hydrolysate. Since each starch molecule has one reducing end, DE is inversely related to molecular weight. The DE of anhydrous D-glucose is defined as 100 and the DE of unhydrolyzed starch is almost zero. Maltodextrin typically has a DE of about 5 to 20. Some types of resistant maltodextrin have a DE of about 8 to 12.5.
Useful resistant starch may be obtained commercially under the trade designation "ACTISTAR RT" (from Cargill Texturizing Solutions). Resistant Maltodextrin:
In some embodiments, the sweetener compositions of the invention comprise resistant maltodextrin. A resistant maltodextrin is defined as a short chain polymer of glucose that is resistant to digestion in the human digestive system. Suitable resistant maltodextrin is commercially available under the trade designation "FIBERSOL-2" (from Archer Daniels Midland Company, Decatur, IL) High Intensity Sweetener:
In some embodiments, the sweetener compositions of the invention comprise a natural or synthetic high intensity sweetener. Examples of useful high intensity sweeteners include sucralose (l ,6-dichloro-l,6-dideoxy-β-D-fructo-furanosyl 4- chloro^-deoxy-α-D-galactopyranoside; "SPLENDA" from Tate & LyIe), acesulfame potassium (potassium salt of 6-methyl- 1,2,3- oxathiazine-4(3H)-one 2,2- dioxide; (SUNETT" from Nutrinova)), N-[N-(3,3-dimethylbutyl)-L-aspartyl]-L-
phenylaniline 1 -methyl ester ("NEOTAME" from NutraSweet), aspartame (7V-L-a- aspartyl-L-phenylalanine 1 -methyl ester ("EQUAL" from Merisant Co.)), saccharin, alitame, cyclamate (Na or K salt of cyclohexanesulfamic acid), monatin (and its salts), monellin, glycyrrhizin (and its salts), thaumatin, stevia, compounds derived from stevia (e.g., rebaudiosides and steviosides), brazzein, neohesperidin dihydrochalcone (NHDC), 3,4-dihydroxybenzylamine (DHBA), Io han guo, or any approved sweeteners potentiator, and the like. Mixtures of high intensity sweeteners may also be used.
When included, a high intensity sweetener is typically incorporated in an amount up to about 0.4 wt.% of the composition, for example, about 0.1 wt.% to about 0.2 wt.%. In some embodiments a combination of two or more high intensity sweeteners is used. For example, a useful combination of high intensity sweeteners is acesulfame potassium and neotame. The use of these two high intensity sweeteners has been found to provide a desirable sweetness profile. Acesulfame potassium tends to provide an initial sweet taste whereas neotame acts to maintain a sweet flavor profile over time. Typically, the weight ratio of acesulfame potassium to neotame in the sweetener composition ranges from about 8: 1 to about 16.7: 1 , more typically ranging from about 9: 1 to about 10: 1. Based upon the weight of the formulation, the amount of acesulfame potassium typically ranges from about 0.09 wt.% to about 0.18 wt.% and the amount of neotame typically ranges from about 0.006 wt.% to about 0.01 1 wt.%. Sweetener Compositions:
The sweetener compositions of the invention may be utilized for any application where a sugar-free sweetener is desired. For example, the sweetener composition may be used in a food or a beverage. Typical applications of the sweetener composition include baked goods such as breads, cookies, cakes, brownies, and the like; beverages such as coffee and soft drinks; confections such as chocolates, candies, the like; dairy products such as cheesecake, ice cream, smoothies, yogurt, and the like; cereal bars, health bars, protein bars and the like. The sweetener compositions of the invention may be manufactured in any manner. Typically, the compositions are produced by mixing or dry blending the components making up the sweetener composition.
Digestive Tolerance:
In many embodiments, the sweetener compositions of the invention have improved gastrointestinal tolerance in humans. For example, the sweetener compositions of the invention have improved gastrointestinal tolerance as compared to maltitol. Gastrointestinal tolerance can be measured, for example, using a randomized, double blind, crossover, repeated measure design protocol, such described in Test Protocol 1 in the Example section of the application. In a representative test, a test food comprising a sweetener to be tested is consumed by human subjects, and the subjects are required to complete a gastrointestinal survey at various intervals, prior to and after, consuming the test food. For example, the human subject may complete the survey at 0 hours (i.e., just prior to consuming the test food), 2 hours, 6 hours, 12 hours, and 24 hours after consuming the test food. The food is then rated at the various time periods for gastrointestinal tolerance as evidenced by gastrointestinal effects such as gastrointestinal rumbling, abdominal cramping, gas/bloating, excessive flatulence, loose stools, and diarrhea. The reduction in one or more of these gastrointestinal effects is evidence of improved gastrointestinal tolerance for the sweetener composition as compared to the comparative sweetener (e.g., maltitol). Typically, improved gastrointestinal tolerance is evidenced by a reduction in more than one gastrointestinal effect for the sweetener composition as compared to the comparative sweetener composition.
The invention will now be described with reference to the following non- limiting Examples.
EXAMPLES The objective of the study was to evaluate and compare the gastrointestinal effects of iced cupcakes prepared with a sweetener composition of the invention to an iced cupcake prepared with maltitol and a sweetener comprising resistant maltodextrin. Test Protocol 1 : Study Design and Methods:
The study used a randomized, double-blind, crossover, repeated measure design. Gastrointestinal symptoms were entered into an on-line questionnaire prior
to consuming the cupcake and at 2, 6 12 and 24 hours following the consumption of the cupcake. Consumption of the cupcakes took place on Tuesday morning for a consecutive three-week period. Participants were asked to rate the following symptoms: gastrointestinal rumbling, abdominal cramping, abdominal gas/bloating, excessive flatulence and loose stools on a five point scale with the following descriptors: none, mild, moderate, strong and very strong. Diarrhea was recorded as a yes/no response. Differences in scores between the test foods were tested by a Wilcoxon signed-rank test. Statistical analysis was performed by SAS. Subjects:
Seventy individual participants were included in the in-house study. The participants were screened by a questionnaire pertaining to general health and gastrointestinal condition. They appeared to be healthy and claimed they did not have a gastrointestinal condition that could potentially interfere with the absorption or toleration of the test foods. None of the participants reported being constipated. Materials:
Three sweetener compositions were evaluated. Sweetener 1 was an embodiment of the present invention. Comparative Sweetener A consisted of 100% maltitol. Comparative Sweetener B was a comparative sweetener composition comprising resistant maltodextrin.
SWEETENER FORMULATION 1
COMPARATIVE SWEETENER B:
Preparation of Cupcakes:
Eighty (80) gram iced cupcakes were prepared in the Cargill bake lab. Each cupcake consisted of 45 grams of baked cake that was coated with 35 grams of icing. The sweetener to be tested was included in both the cake and icing portions of each cupcake in an amount shown in the recipes provided below.
Preparation of Cake Batter:
Cake batters were prepared having the recipe shown in TABLE 1. Each cake batter was prepared from a standard yellow cake base having the ingredients shown in TABLE 2.
TABLE 2: Standard Yellow Cake Base
After baking the cupcakes, each cupcake was iced with an icing composition comprising the same sweetener that was used in the cake batter. That is, Cake Batter 1 was used with Icing Formulation 1 to provide a cupcake comprising SWEETENER 1 ; Cake Batter 2 was used with Icing Formulation 2 to provide a cupcake comprising COMP. SWEETENER A; and Cake Batter 3 was used with Icing Formulation 3 to provide a cupcake comprising COMP. SWEETENER B. The white icings had the recipes listed in TABLE 3.
TABLE 3 White Icin Formulations
Results:
Generally speaking, the gastrointestinal symptoms increased after consuming the cupcakes and peaked after 6 hours. The gastrointestinal symptoms generally returned to baseline after 24 hours. Significantly milder gastrointestinal symptoms were reported for several of the symptoms after consuming the cupcakes comprising SWEETENER 1 when compared to the cupcakes comprising COMP. SWEETNER A. In addition, significantly milder gastrointestinal symptoms were reported for several of the symptoms after consuming the cupcakes comprising COMP. SWEETENER B when compared to the cupcakes comprising COMP. SWEETNER A. More specifically, significantly milder gastrointestinal rumbling, abdominal cramping, abdominal gas/bloating and excessive flatulence symptoms were reported 6 hours after consumption for the cupcakes comprising SWEETENER 1 as
compared to the cupcakes comprising COMP. SWEETENER A, and also as compared to the cupcakes comprising COMP. SWEETENER B. Significantly milder abdominal cramping was reported for COMP. SWEETENER B as compared to COMP. SWEETENER A at 12 hours after consumption. Significantly milder abdominal cramping was reported after 24 hours for COMP. SWEETENER A as compared to SWEETENER 1. There was no difference in any of the symptoms prior to consuming the cupcakes or two hours after consumption, and no significant difference in loose stools at any time point. A small number of participants reported having diarrhea with all three test foods. The detailed results are provided in TABLE
10 4.
TABLE 4: P-Values - Pairwise Treatment Comparison
Shaded blocks identify comparisons having a significant P-value of P < 0.05.
15
Discussion:
The milder symptoms experienced after ingesting foods comprising SWEETENER 1 may be attributed to the composition of the sweetener. Erythritol is a better tolerated low-digestible carbohydrate as compared to maltitol because about
20 90% of it is absorbed in the small intestine and excreted unchanged in the urine. The remainder undergoes colonic fermentation. The resistant starch may contribute to the milder gastrointestinal symptoms in that any symptoms resulting therefrom may be experienced at a different time points and therefore not contribute to the cumulative symptoms of the polyols. In using a combination of ingredients with differing types
and rates of symptoms, SWEETENER 1 was observed to be better tolerated than maltitol.
Other embodiments of this invention will be apparent to those skilled in the art upon consideration of this specification or from practice of the invention disclosed herein. Various omissions, modifications, and changes to the principles and embodiments described herein may be made by one skilled in the art without departing from the true scope and spirit of the invention which is indicated by the following claims. All patents, patent documents, and publications cited herein are hereby incorporated by reference as if individually incorporated.
Claims
1. A low calorie sweetener composition comprising: (a) about 5 wt.% to about 40 wt.% erythritol; (b) 0 wt.% to about 30 wt.% sorbitol; (c) 0 wt.% to about 50 wt.% isomalt, maltitol, or a mixture thereof; (d) about 5 wt.% to about 40 wt.% resistant starch; and (e) about 5 wt.% to about 40 wt.% polydextrose.
2. The sweetener composition of claim 1 , wherein the sweetener composition further includes a high intensity sweetener.
3. The sweetener composition of claim 2, wherein the high intensity sweetener is present in an amount of about 0.4 wt.% or less. 4. The sweetener composition of claim 2, wherein the high intensity sweetener is selected from the group consisting of sucralose, acesulfame potassium, neotame, aspartame, saccharin, alitame, cyclamate, monellin, monatin and it salts, glycyrrhizin and its salts, thaumatin, stevia, compounds derived from stevia, brazzein, neohesperidin dihydrochalcone, 3,
4-dihydroxybenzylamine, Io han guo, a sweetness potentiator, and mixtures thereof.
5. The sweetener composition of claim 2, wherein the high intensity sweetener comprises neotame and acesulfame potassium.
6. The sweetener composition of claim 5, wherein neotame is present in an amount of about 0.006 wt.% to about 0.01 1 wt.% and wherein acesulfame potassium is present in an amount of about 0.09 wt.% to about 0.18 wt.%.
7. The sweetener composition of claim 1 , wherein the erythritol is present in an amount of about 25 wt.% to about 35 wt.%.
8. The sweetener composition of claim 1, wherein the sorbitol is present in an amount of about 10 wt.% to about 20 wt.%.
9. The sweetener composition of claim 1 , wherein the isomalt, maltitol, or mixture thereof is present in an amount ranging from about 25 wt.% to about 35 wt.%.
10. The sweetener composition of claim 1, wherein maltitol is present in an amount ranging from about 15 wt.% to about 45 wt.%.
1 1. The sweetener composition of claim 1, wherein isomalt is present in an amount ranging from about 25 wt.% to about 35 wt.%.
12. The sweetener composition of claim 1 , wherein the polydextrose is present in an amount ranging from about 10 wt.% to about 20 wt.%.
13. The sweetener composition of claim 1, wherein the resistant starch is present in an amount ranging from about 5 wt.% to about 20 wt.%.
14. The sweetener composition of claim 1 , wherein the resistant starch is a RSl, RS2, RS3, or RS4 type resistant starch.
15. The sweetener composition of claim 1, wherein the resistant starch is an RS4 type resistant starch.
16. The sweetener composition of claim 1, wherein the resistant starch has a dextrose equivalent of about 100.
17. A food composition comprising the sweetener composition of claim 1.
18. The food composition of claim 17, wherein the food composition is a baked good, a confectionary, a dairy product, a cereal bar, a health bar, and a protein bar,
19. The food composition according to claim 17, wherein the food composition is a baked good.
20. A beverage composition comprising a beverage and the sweetener composition of claim 1.
21. The sweetener composition of claim 1, wherein the sweetener composition has improved gastrointestinal tolerance as compared to maltitol.
22. The sweetener composition of claim 1 , wherein the sweetener composition has improved gastrointestinal tolerance as compared to maltitol when measured using Test Protocol 1.
23. The sweetener composition of claim 22, wherein the sweetener composition has improved gastrointestinal tolerance as compared to maltitol when measured using Protocol 1 at 6 hours.
24. A sweetener composition comprising: (a) about 25 wt.% to about 35 wt.% erythritol; (b) about 10 wt.% to about 20 wt.% sorbitol; (c) about 25 wt.% to about 30 wt.% isomalt, maltitol, or a mixture thereof; (d) about 5 wt.% to about 20 wt.% resistant starch; (e) about 10 wt.% to about 20 wt.% polydextrose; and (f) about 0.4 wt.% or less of a high intensity sweetener comprising neotame and acesulfame potassium.
25. A sweetener composition comprising: (a) about 5 wt.% to about 40 wt.% erythritol; (b) up to about 68 wt.% of an ingredient selected from isomalt, maltitol, sorbitol, or a mixture thereof; (c) about 5 wt.% to about 40 wt.% of an ingredient selected from polydextrose, resistant maltodextrin, or a mixture thereof, i 26. The sweetener composition of claim 25, wherien the sweetener comprises about 29 wt.% polydextrose, about 57% maltitol, and about 14% erythritol.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07868074A EP2129239A2 (en) | 2006-12-28 | 2007-12-28 | Low calorie sweetener compositions |
CA002673773A CA2673773A1 (en) | 2006-12-28 | 2007-12-28 | Low calorie sweetener compositions |
US12/521,152 US20100112174A1 (en) | 2006-12-28 | 2007-12-28 | Low calorie sweetener compositions |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87752506P | 2006-12-28 | 2006-12-28 | |
US60/877,525 | 2006-12-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008082596A2 true WO2008082596A2 (en) | 2008-07-10 |
WO2008082596A3 WO2008082596A3 (en) | 2008-08-28 |
Family
ID=39495147
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2007/026396 WO2008082596A2 (en) | 2006-12-28 | 2007-12-28 | Low calorie sweetener compositions |
Country Status (4)
Country | Link |
---|---|
US (1) | US20100112174A1 (en) |
EP (1) | EP2129239A2 (en) |
CA (1) | CA2673773A1 (en) |
WO (1) | WO2008082596A2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015158735A1 (en) * | 2014-04-14 | 2015-10-22 | Aegis Nv | Sugar replacement composition |
WO2016097067A1 (en) * | 2014-12-16 | 2016-06-23 | Aegis Nv | Sugar replacement composition |
WO2016171559A1 (en) * | 2015-04-24 | 2016-10-27 | Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno | Food products with reduced sugar content |
WO2017051166A1 (en) * | 2015-09-23 | 2017-03-30 | Tate & Lyle Ingredients Americas Llc | Methods for improving the gastrointestinal tolerance of food and beverage products comprising sweet, low-digestible carbohydrates |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7297800B2 (en) * | 2001-12-27 | 2007-11-20 | Ajinomoto Co., Inc. | Process of producing glutamate derivatives |
DK1533376T3 (en) | 2002-08-26 | 2010-07-19 | Ajinomoto Kk | Novel aldolases and processes for preparing substituted alpha-keto acid |
BR0316927A (en) | 2002-12-09 | 2005-10-18 | Ajinomoto Kk | Protein, methods for producing an optically active glutamic acid derivative and for producing a protein having d-aminotransferase, dna, cell activity. |
US20110070337A1 (en) * | 2009-09-21 | 2011-03-24 | Whitewave Services, Inc. | Reduced Calorie Soy Beverage |
US8828466B2 (en) * | 2010-11-16 | 2014-09-09 | Kellogg Company | Ready-to-eat cereal with reduced sugar coating |
AR087157A1 (en) | 2011-06-20 | 2014-02-26 | Gen Biscuit | HEALTHY COCKTAIL |
JP7364181B2 (en) * | 2018-03-13 | 2023-10-18 | 国立大学法人岩手大学 | Composition for low-sugar confectionery and low-sugar confectionery using the same |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0447359A1 (en) * | 1990-03-12 | 1991-09-18 | McNEIL-PPC, INC. | Synergistic sweetening compositions containing polydextrose and a chlorodeoxysugar and methods for preparing same |
US6045850A (en) * | 1997-05-08 | 2000-04-04 | M & C Sweeteners, Llc | Low-calorie compounded cocoa composition |
KR20020007724A (en) * | 2000-07-18 | 2002-01-29 | 정기련 | Agglomerated erythritol powder composition having improved flavor and preparation process thereof |
WO2005070183A2 (en) * | 2004-01-13 | 2005-08-04 | Spi Polyols, Inc. | Ice cream and ice cream formulations containing maltitol |
WO2005087020A1 (en) * | 2004-03-05 | 2005-09-22 | Richmond Chemical Corporation | High-intensity sweetener-polyol compositions |
US20060172053A1 (en) * | 2005-01-24 | 2006-08-03 | Hahn Patricia W | Reduced sugar sweet roll |
US20060286248A1 (en) * | 2003-10-02 | 2006-12-21 | Anfinsen Jon R | Reduced-carbohydrate and nutritionally-enhanced frozen desserts and other food products |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3766165A (en) * | 1966-08-17 | 1973-10-16 | Pfizer | Polysaccharides and their preparation |
US3876794A (en) * | 1972-12-20 | 1975-04-08 | Pfizer | Dietetic foods |
US5659028A (en) * | 1990-02-23 | 1997-08-19 | Raffinerie Tirlemontoise S.A. | Branched fructo-oligosaccharides, method for obtaining them and use of products containing them |
US5281276A (en) * | 1992-03-25 | 1994-01-25 | National Starch And Chemical Investment Holding Corporation | Process for making amylase resistant starch from high amylose starch |
US5409542A (en) * | 1992-03-25 | 1995-04-25 | National Starch And Chemical Investment Holding Corporation | Amylase resistant starch product form debranched high amylose starch |
US5916606A (en) * | 1993-09-30 | 1999-06-29 | Wm. Wrigley Jr. Company | Chewing gum compositions containing erythritol and a moisture binding agent |
US5593503A (en) * | 1995-06-07 | 1997-01-14 | National Starch And Chemical Investment Holding Corporation | Process for producing amylase resistant granular starch |
GB9625129D0 (en) * | 1996-12-03 | 1997-01-22 | Cerestar Holding Bv | Highly fermentable resistant starch |
US5855946A (en) * | 1997-06-06 | 1999-01-05 | Kansas State University Research Foundation | Food grade starch resistant to α-amylase and method of preparing the same |
US6616960B2 (en) * | 1998-11-17 | 2003-09-09 | Cerestar Holding, B.V. | Baked good covered with sugar-free cream icing |
US20040170735A2 (en) * | 2002-04-05 | 2004-09-02 | Mcneil-Ppc, Inc. | Methods and compositions for altering the sweetness delivery profile of sucralose |
CA2531065A1 (en) * | 2003-07-10 | 2005-01-27 | Smithkline Beecham Corporation | Pharmaceutical compositions |
-
2007
- 2007-12-28 WO PCT/US2007/026396 patent/WO2008082596A2/en active Application Filing
- 2007-12-28 EP EP07868074A patent/EP2129239A2/en not_active Withdrawn
- 2007-12-28 CA CA002673773A patent/CA2673773A1/en not_active Abandoned
- 2007-12-28 US US12/521,152 patent/US20100112174A1/en not_active Abandoned
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0447359A1 (en) * | 1990-03-12 | 1991-09-18 | McNEIL-PPC, INC. | Synergistic sweetening compositions containing polydextrose and a chlorodeoxysugar and methods for preparing same |
US6045850A (en) * | 1997-05-08 | 2000-04-04 | M & C Sweeteners, Llc | Low-calorie compounded cocoa composition |
KR20020007724A (en) * | 2000-07-18 | 2002-01-29 | 정기련 | Agglomerated erythritol powder composition having improved flavor and preparation process thereof |
US20060286248A1 (en) * | 2003-10-02 | 2006-12-21 | Anfinsen Jon R | Reduced-carbohydrate and nutritionally-enhanced frozen desserts and other food products |
WO2005070183A2 (en) * | 2004-01-13 | 2005-08-04 | Spi Polyols, Inc. | Ice cream and ice cream formulations containing maltitol |
WO2005087020A1 (en) * | 2004-03-05 | 2005-09-22 | Richmond Chemical Corporation | High-intensity sweetener-polyol compositions |
US20060172053A1 (en) * | 2005-01-24 | 2006-08-03 | Hahn Patricia W | Reduced sugar sweet roll |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015158735A1 (en) * | 2014-04-14 | 2015-10-22 | Aegis Nv | Sugar replacement composition |
JP2017513523A (en) * | 2014-04-14 | 2017-06-01 | アイヒス エヌヴイAegis Nv | Alternative sugar composition |
WO2016097067A1 (en) * | 2014-12-16 | 2016-06-23 | Aegis Nv | Sugar replacement composition |
WO2016171559A1 (en) * | 2015-04-24 | 2016-10-27 | Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno | Food products with reduced sugar content |
EP3285589B1 (en) | 2015-04-24 | 2021-11-17 | Koninklijke Peijnenburg B.V. | Food products with reduced sugar content |
EP4032407A1 (en) * | 2015-04-24 | 2022-07-27 | Koninklijke Peijnenburg B.V. | Food products with reduced sugar content |
WO2017051166A1 (en) * | 2015-09-23 | 2017-03-30 | Tate & Lyle Ingredients Americas Llc | Methods for improving the gastrointestinal tolerance of food and beverage products comprising sweet, low-digestible carbohydrates |
CN108289486A (en) * | 2015-09-23 | 2018-07-17 | 泰特&莱尔组分美国公司 | For improving the method comprising the food of the low digestible carbohydrates of sweet taste and the gastrointestinal tolerance of drink |
US10933074B2 (en) | 2015-09-23 | 2021-03-02 | Tate & Lyle Ingredients Americas Llc | Methods for improving the gastrointestinal tolerance of food and beverage products comprising sweet, low-digestible carbohydrates |
Also Published As
Publication number | Publication date |
---|---|
US20100112174A1 (en) | 2010-05-06 |
WO2008082596A3 (en) | 2008-08-28 |
EP2129239A2 (en) | 2009-12-09 |
CA2673773A1 (en) | 2008-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20100112174A1 (en) | Low calorie sweetener compositions | |
JP5314076B2 (en) | Bulking agent for baked products | |
JP3490106B2 (en) | Preparation of arbitrarily hydrogenated indigestible polysaccharides | |
EP1676486B1 (en) | Frozen confection | |
US20140377436A1 (en) | Low Calorie Sugar Substitute Composition and Methods for Making the Same | |
WO1998004156A1 (en) | Dietetic one-to-one sugar substitute composition for table top, baking and cooking applications | |
US20220338516A1 (en) | Oligosaccharide compositions and methods of making them | |
WO2013041236A1 (en) | Sweetener compositions, methods of making same and consumables containing same | |
MXPA05013531A (en) | Frozen confection and process for manufacture of frozen confection. | |
KR20200002012A (en) | Saccharide mixture containing malto oligosaccharides | |
Auerbach et al. | Bulking Agents–Multi‐Functional Ingredients | |
Grembecka | Sugar alcohols as sugar substitutes in food industry | |
EP2136652B1 (en) | Reducing the sensory cooling effect of polyols | |
Mariotti et al. | Sugar and sweeteners | |
EP3481207B1 (en) | Reduced sugar wafer | |
US20210084954A1 (en) | Fibre-based composition and use thereof for the preparation of food products | |
JP2022540364A (en) | Fruit preparations containing reduced sugar solutions and starch and other sweet sauces | |
WO2015134374A1 (en) | Coating compositions for consumable articles | |
JPWO2021140225A5 (en) | ||
CA2841443A1 (en) | No sugar confectioners blend composition | |
WO2023081096A1 (en) | Methods and systems for production of high fiber baked goods |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 2673773 Country of ref document: CA |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007868074 Country of ref document: EP |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07868074 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12521152 Country of ref document: US |